Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative option in the treatment of aggressive malignant and non-malignant blood disorders. However, the benefits of allo-HSCT can be compromised by graft-versus-host disease (GvHD), a prevalent and morbid complication of allo-HSCT....

Full description

Bibliographic Details
Main Authors: Kudakwashe Mhandire, Komalpreet Saggu, Nataliya Prokopenko Buxbaum
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/11/11/736